nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—PGD—Methotrexate—psoriatic arthritis	0.87	1	CbGbCtD
Gadopentetate dimeglumine—Bradycardia—Prednisone—psoriatic arthritis	0.000319	0.00245	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Triamcinolone—psoriatic arthritis	0.000315	0.00242	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Methylprednisolone—psoriatic arthritis	0.000314	0.00241	CcSEcCtD
Gadopentetate dimeglumine—Abdominal discomfort—Methotrexate—psoriatic arthritis	0.000313	0.0024	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Dexamethasone—psoriatic arthritis	0.000313	0.0024	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Betamethasone—psoriatic arthritis	0.000313	0.0024	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Triamcinolone—psoriatic arthritis	0.000311	0.00239	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Methylprednisolone—psoriatic arthritis	0.00031	0.00238	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Triamcinolone—psoriatic arthritis	0.000309	0.00237	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Methylprednisolone—psoriatic arthritis	0.000309	0.00237	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Prednisone—psoriatic arthritis	0.000308	0.00236	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.000306	0.00235	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Triamcinolone—psoriatic arthritis	0.000303	0.00233	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Methylprednisolone—psoriatic arthritis	0.000302	0.00232	CcSEcCtD
Gadopentetate dimeglumine—Shock—Prednisolone—psoriatic arthritis	0.000301	0.00231	CcSEcCtD
Gadopentetate dimeglumine—Cough—Triamcinolone—psoriatic arthritis	0.000301	0.00231	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Triamcinolone—psoriatic arthritis	0.000299	0.00229	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Prednisolone—psoriatic arthritis	0.000299	0.00229	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Methylprednisolone—psoriatic arthritis	0.000298	0.00229	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Triamcinolone—psoriatic arthritis	0.000298	0.00229	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Methylprednisolone—psoriatic arthritis	0.000297	0.00228	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000296	0.00227	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000293	0.00225	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Prednisone—psoriatic arthritis	0.000293	0.00225	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Methylprednisolone—psoriatic arthritis	0.000292	0.00224	CcSEcCtD
Gadopentetate dimeglumine—Drowsiness—Methotrexate—psoriatic arthritis	0.000291	0.00224	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000291	0.00223	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Prednisone—psoriatic arthritis	0.000291	0.00223	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Triamcinolone—psoriatic arthritis	0.000287	0.0022	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Methotrexate—psoriatic arthritis	0.000287	0.0022	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Betamethasone—psoriatic arthritis	0.000286	0.00219	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Dexamethasone—psoriatic arthritis	0.000286	0.00219	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Prednisone—psoriatic arthritis	0.000284	0.00218	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000283	0.00217	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Methylprednisolone—psoriatic arthritis	0.000283	0.00217	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Prednisone—psoriatic arthritis	0.000283	0.00217	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Dexamethasone—psoriatic arthritis	0.000282	0.00217	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Betamethasone—psoriatic arthritis	0.000282	0.00217	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000281	0.00216	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000281	0.00216	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Dexamethasone—psoriatic arthritis	0.000281	0.00215	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Betamethasone—psoriatic arthritis	0.000281	0.00215	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Prednisone—psoriatic arthritis	0.00028	0.00215	CcSEcCtD
Gadopentetate dimeglumine—Sweating—Methotrexate—psoriatic arthritis	0.000279	0.00214	CcSEcCtD
Gadopentetate dimeglumine—Shock—Triamcinolone—psoriatic arthritis	0.000277	0.00213	CcSEcCtD
Gadopentetate dimeglumine—Shock—Methylprednisolone—psoriatic arthritis	0.000276	0.00212	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000276	0.00212	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000275	0.00211	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000275	0.00211	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000275	0.00211	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000275	0.00211	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000275	0.00211	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Prednisone—psoriatic arthritis	0.000274	0.0021	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000274	0.0021	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000273	0.00209	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Prednisone—psoriatic arthritis	0.000273	0.00209	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000272	0.00209	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000272	0.00208	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Dexamethasone—psoriatic arthritis	0.000271	0.00208	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Betamethasone—psoriatic arthritis	0.000271	0.00208	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Dexamethasone—psoriatic arthritis	0.00027	0.00207	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Betamethasone—psoriatic arthritis	0.00027	0.00207	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Dexamethasone—psoriatic arthritis	0.000266	0.00204	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Betamethasone—psoriatic arthritis	0.000266	0.00204	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000262	0.00201	CcSEcCtD
Gadopentetate dimeglumine—Pain—Prednisolone—psoriatic arthritis	0.000262	0.00201	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000258	0.00198	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Methotrexate—psoriatic arthritis	0.000256	0.00197	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000256	0.00197	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000256	0.00196	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000255	0.00196	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000255	0.00196	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000253	0.00194	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000252	0.00194	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000252	0.00194	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Methotrexate—psoriatic arthritis	0.000252	0.00193	CcSEcCtD
Gadopentetate dimeglumine—Shock—Dexamethasone—psoriatic arthritis	0.000251	0.00193	CcSEcCtD
Gadopentetate dimeglumine—Shock—Betamethasone—psoriatic arthritis	0.000251	0.00193	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000251	0.00193	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00025	0.00192	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00025	0.00192	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Prednisone—psoriatic arthritis	0.00025	0.00192	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000249	0.00191	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Betamethasone—psoriatic arthritis	0.000249	0.00191	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Prednisone—psoriatic arthritis	0.000249	0.00191	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Methotrexate—psoriatic arthritis	0.000247	0.0019	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000247	0.00189	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000247	0.00189	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Prednisone—psoriatic arthritis	0.000246	0.00189	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Methotrexate—psoriatic arthritis	0.000245	0.00188	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Prednisone—psoriatic arthritis	0.000244	0.00188	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Methotrexate—psoriatic arthritis	0.000244	0.00187	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Dexamethasone—psoriatic arthritis	0.000243	0.00187	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Betamethasone—psoriatic arthritis	0.000243	0.00187	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Prednisolone—psoriatic arthritis	0.000243	0.00187	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000243	0.00186	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Triamcinolone—psoriatic arthritis	0.000243	0.00186	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Methylprednisolone—psoriatic arthritis	0.000242	0.00186	CcSEcCtD
Gadopentetate dimeglumine—Pain—Triamcinolone—psoriatic arthritis	0.000241	0.00185	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Prednisone—psoriatic arthritis	0.00024	0.00184	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Betamethasone—psoriatic arthritis	0.000239	0.00183	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Dexamethasone—psoriatic arthritis	0.000239	0.00183	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Methotrexate—psoriatic arthritis	0.000237	0.00182	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Methotrexate—psoriatic arthritis	0.000236	0.00181	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Prednisone—psoriatic arthritis	0.000236	0.00181	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000236	0.00181	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Prednisone—psoriatic arthritis	0.000235	0.00181	CcSEcCtD
Gadopentetate dimeglumine—Chills—Methotrexate—psoriatic arthritis	0.000235	0.0018	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000233	0.00179	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000233	0.00179	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Prednisone—psoriatic arthritis	0.000232	0.00178	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000232	0.00178	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000231	0.00178	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Prednisone—psoriatic arthritis	0.000231	0.00177	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00023	0.00177	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00023	0.00176	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000229	0.00176	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000229	0.00176	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Methotrexate—psoriatic arthritis	0.000229	0.00176	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Methotrexate—psoriatic arthritis	0.000228	0.00175	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000226	0.00173	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Triamcinolone—psoriatic arthritis	0.000224	0.00172	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Methylprednisolone—psoriatic arthritis	0.000223	0.00171	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Methotrexate—psoriatic arthritis	0.000223	0.00171	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000223	0.00171	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000222	0.00171	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000222	0.0017	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000222	0.0017	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Betamethasone—psoriatic arthritis	0.000222	0.0017	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000221	0.00169	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000221	0.00169	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Methotrexate—psoriatic arthritis	0.00022	0.00169	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Dexamethasone—psoriatic arthritis	0.00022	0.00169	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Betamethasone—psoriatic arthritis	0.00022	0.00169	CcSEcCtD
Gadopentetate dimeglumine—Shock—Prednisone—psoriatic arthritis	0.000219	0.00168	CcSEcCtD
Gadopentetate dimeglumine—Pain—Dexamethasone—psoriatic arthritis	0.000218	0.00168	CcSEcCtD
Gadopentetate dimeglumine—Pain—Betamethasone—psoriatic arthritis	0.000218	0.00168	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000218	0.00167	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Prednisone—psoriatic arthritis	0.000217	0.00167	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Prednisone—psoriatic arthritis	0.000216	0.00166	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000215	0.00165	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Prednisone—psoriatic arthritis	0.000212	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00021	0.00162	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00021	0.00162	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000209	0.0016	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000209	0.0016	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000207	0.00159	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000207	0.00159	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Methotrexate—psoriatic arthritis	0.000205	0.00158	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Betamethasone—psoriatic arthritis	0.000203	0.00156	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Dexamethasone—psoriatic arthritis	0.000203	0.00156	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000203	0.00156	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Prednisolone—psoriatic arthritis	0.000202	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Triamcinolone—psoriatic arthritis	0.000202	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Betamethasone—psoriatic arthritis	0.000202	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000202	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000202	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000202	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Methylprednisolone—psoriatic arthritis	0.000202	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Prednisone—psoriatic arthritis	0.0002	0.00153	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Triamcinolone—psoriatic arthritis	0.000199	0.00153	CcSEcCtD
Gadopentetate dimeglumine—Cough—Methotrexate—psoriatic arthritis	0.000199	0.00153	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Methylprednisolone—psoriatic arthritis	0.000199	0.00152	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Methotrexate—psoriatic arthritis	0.000197	0.00151	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Methotrexate—psoriatic arthritis	0.000194	0.00149	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Methotrexate—psoriatic arthritis	0.000194	0.00149	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Prednisone—psoriatic arthritis	0.000193	0.00148	CcSEcCtD
Gadopentetate dimeglumine—Rash—Prednisolone—psoriatic arthritis	0.000193	0.00148	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Prednisolone—psoriatic arthritis	0.000193	0.00148	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000193	0.00148	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000192	0.00147	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Prednisone—psoriatic arthritis	0.000192	0.00147	CcSEcCtD
Gadopentetate dimeglumine—Headache—Prednisolone—psoriatic arthritis	0.000192	0.00147	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Prednisone—psoriatic arthritis	0.00019	0.00146	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Methotrexate—psoriatic arthritis	0.000187	0.00144	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Triamcinolone—psoriatic arthritis	0.000186	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000186	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000186	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Prednisone—psoriatic arthritis	0.000183	0.00141	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Dexamethasone—psoriatic arthritis	0.000183	0.00141	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Betamethasone—psoriatic arthritis	0.000183	0.00141	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000182	0.0014	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000182	0.0014	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Prednisolone—psoriatic arthritis	0.000182	0.0014	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Betamethasone—psoriatic arthritis	0.000181	0.00139	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Dexamethasone—psoriatic arthritis	0.000181	0.00139	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Methotrexate—psoriatic arthritis	0.000181	0.00139	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00018	0.00138	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Triamcinolone—psoriatic arthritis	0.000179	0.00137	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000179	0.00137	CcSEcCtD
Gadopentetate dimeglumine—Rash—Triamcinolone—psoriatic arthritis	0.000177	0.00136	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000177	0.00136	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Methotrexate—psoriatic arthritis	0.000177	0.00136	CcSEcCtD
Gadopentetate dimeglumine—Rash—Methylprednisolone—psoriatic arthritis	0.000177	0.00136	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000177	0.00136	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Prednisone—psoriatic arthritis	0.000177	0.00136	CcSEcCtD
Gadopentetate dimeglumine—Headache—Triamcinolone—psoriatic arthritis	0.000176	0.00135	CcSEcCtD
Gadopentetate dimeglumine—Headache—Methylprednisolone—psoriatic arthritis	0.000176	0.00135	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Prednisone—psoriatic arthritis	0.000176	0.00135	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Prednisone—psoriatic arthritis	0.000176	0.00135	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000175	0.00134	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000175	0.00134	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Methotrexate—psoriatic arthritis	0.000174	0.00133	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000169	0.0013	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Dexamethasone—psoriatic arthritis	0.000169	0.0013	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Betamethasone—psoriatic arthritis	0.000169	0.0013	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Triamcinolone—psoriatic arthritis	0.000167	0.00128	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000167	0.00128	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Methylprednisolone—psoriatic arthritis	0.000167	0.00128	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000166	0.00127	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Methotrexate—psoriatic arthritis	0.000165	0.00127	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000164	0.00126	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Betamethasone—psoriatic arthritis	0.000162	0.00125	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Dexamethasone—psoriatic arthritis	0.000162	0.00125	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Methotrexate—psoriatic arthritis	0.000162	0.00124	CcSEcCtD
Gadopentetate dimeglumine—Rash—Betamethasone—psoriatic arthritis	0.000161	0.00124	CcSEcCtD
Gadopentetate dimeglumine—Rash—Dexamethasone—psoriatic arthritis	0.000161	0.00124	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Betamethasone—psoriatic arthritis	0.000161	0.00123	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000161	0.00123	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.00016	0.00123	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Methotrexate—psoriatic arthritis	0.00016	0.00123	CcSEcCtD
Gadopentetate dimeglumine—Headache—Betamethasone—psoriatic arthritis	0.00016	0.00123	CcSEcCtD
Gadopentetate dimeglumine—Headache—Dexamethasone—psoriatic arthritis	0.00016	0.00123	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Prednisone—psoriatic arthritis	0.00016	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Pain—Methotrexate—psoriatic arthritis	0.000159	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Prednisone—psoriatic arthritis	0.000157	0.00121	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000153	0.00118	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Prednisone—psoriatic arthritis	0.000152	0.00117	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000152	0.00117	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Betamethasone—psoriatic arthritis	0.000152	0.00116	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Dexamethasone—psoriatic arthritis	0.000152	0.00116	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Methotrexate—psoriatic arthritis	0.000148	0.00113	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Prednisone—psoriatic arthritis	0.000147	0.00113	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000147	0.00113	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000147	0.00113	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Prednisone—psoriatic arthritis	0.000141	0.00109	CcSEcCtD
Gadopentetate dimeglumine—Rash—Prednisone—psoriatic arthritis	0.00014	0.00108	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Prednisone—psoriatic arthritis	0.00014	0.00108	CcSEcCtD
Gadopentetate dimeglumine—Headache—Prednisone—psoriatic arthritis	0.000139	0.00107	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000137	0.00105	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Methotrexate—psoriatic arthritis	0.000133	0.00102	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Prednisone—psoriatic arthritis	0.000132	0.00101	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Methotrexate—psoriatic arthritis	0.000132	0.00101	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Methotrexate—psoriatic arthritis	0.000127	0.000976	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Methotrexate—psoriatic arthritis	0.000123	0.000943	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Methotrexate—psoriatic arthritis	0.000118	0.000907	CcSEcCtD
Gadopentetate dimeglumine—Rash—Methotrexate—psoriatic arthritis	0.000117	0.000899	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Methotrexate—psoriatic arthritis	0.000117	0.000899	CcSEcCtD
Gadopentetate dimeglumine—Headache—Methotrexate—psoriatic arthritis	0.000116	0.000894	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Methotrexate—psoriatic arthritis	0.00011	0.000847	CcSEcCtD
